Should You Buy Manhattan Associates, Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Manhattan Associates, Inc. (MANH) stands out as one of the highest-quality businesses in our coverage universe, earning a Quality of Company score of 9.6/10. At a current price of $209.62 and a market capitalization of $12.2B, the core investment question is whether the stock offers a compelling entry point relative to its estimated intrinsic value.
The short answer: 0 of 9 CirclFi valuation models project upside for Manhattan Associates, Inc. (MANH) at $209.62 — the model consensus leans bearish, with a Quality Score of 9.6/10 and Value-Trap risk of 6/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Manhattan Associates, Inc. (MANH) in 2026?
What Is the Bull Case vs the Bear Case for Manhattan Associates, Inc. (MANH)?
| Bull case | Bear case — $35.08 target (-83.3%) |
|---|---|
| No active model projects meaningful upside for MANH at $209.62. Bulls would have to argue that qualitative factors the models cannot measure will unlock value. | According to the CirclFi Deep Alpha Valuation Engine, the EROIC Spread model sees the stock as overvalued with a fair value of $35.08 (-83.3%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, the wide model spread of +68.5% reflects fundamental divergence on key assumptions (growth, cost of capital) depending on the methodology. | |
| Industry headwind: valuation multiple compression represents a meaningful risk for Manhattan Associates, Inc. and its Software - Application peers. |
How Does MANH Compare to Its Software - Application Peers?
Valuation data pages: PCTY · IDCC · ZM · CRM · PAYC · NOW · GRND · XPER · MFON · ADSK · PTC
Which Other Stocks Score Like MANH on Quality?
Closest companies to MANH’s Quality of Company score of 9.6/10, across all industries.
- FFIV — F5, Inc. (QOC 9.6) · analysis
- BKTI — BK Technologies Corporation (QOC 9.6) · analysis
- EXEL — Exelixis, Inc. (QOC 9.6) · analysis
- UTHR — United Therapeutics Corporation (QOC 9.6) · analysis
- MRK — Merck & Co., Inc. (QOC 9.6) · analysis
- GOOG — Alphabet Inc. (QOC 9.6) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Software - Application Screens Does MANH Appear In?
So Is Manhattan Associates, Inc. (MANH) Worth Buying in 2026?
Our valuation engine sends a clear cautionary signal on Manhattan Associates, Inc. at $209.62. 9/9 models flag overvaluation, median fair value sits at $84.62 (-59.6%), and the risk-reward profile appears unfavorable. Quality at 9.6/10 is the one bright spot, but premium quality at the wrong price can still destroy returns. This is a stock where patience — or avoidance — may be the optimal strategy.
These are quantitative model outputs, not investment recommendations. Manhattan Associates, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About MANH Stock?
Should I buy MANH stock right now?
Based on CirclFi's multi-model analysis, 0 of 9 models see upside for MANH at $209.62. No active models currently project upside, suggesting the market price may already reflect or exceed fair value. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Manhattan Associates, Inc.?
Key risks include: wide model disagreement (409% spread), signaling high uncertainty; general market and sector-specific risks affecting Software - Application companies. Always diversify and consult a financial advisor.
How does MANH compare to its competitors?
Among Software - Application peers, MANH holds a Quality Score of 9.6/10. Comparable companies include PCTY (QOC 9.6), IDCC (QOC 9.5), ZM (QOC 9.6). The relative ranking helps investors identify whether MANH offers better fundamental quality than alternatives in the same sector.
Is MANH a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. MANH's Quality Score of 9.6/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.
What price should I buy MANH at?
CirclFi does not provide target buy prices or price alerts. However, our 9 active models produce fair value estimates ranging from $35.08 to $178.67. At $209.62, the stock trades above all model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for MANH.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad